Caulis, Inc. (JP:153A)
:153A
153A Stock Chart & Stats
¥2129.00
-¥52.00(-3.54%)
At close: 4:00 PM EST
¥2129.00
-¥52.00(-3.54%)
Day’s Range― - ―
52-Week Range¥688.00 - ¥2,888.00
Previous CloseN/A
Volume54.50K
Average Volume (3M)92.42K
Market Cap
¥7.29B
Enterprise Value¥5.87B
Total Cash (Recent Filing)¥1.88B
Total Debt (Recent Filing)¥250.00M
Price to Earnings (P/E)33.1
Beta1.35
Next Earnings
May 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.88
Shares Outstanding6,530,800
10 Day Avg. Volume64,850
30 Day Avg. Volume92,423
Financial Highlights & Ratios
PEG Ratio-7.19
Price to Book (P/B)4.57
Price to Sales (P/S)5.41
P/FCF Ratio36.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue AccelerationSustained, large revenue acceleration (≈108.9% in 2025) indicates durable demand and successful product-market fit. Over a 2–6 month horizon this supports continued scale benefits, stronger customer economics, and the ability to fund product development and market expansion without relying solely on external financing.
High Profitability MarginsRelatively high gross, operating and net margins signal structural competitive advantages—pricing power, efficient cost structure, or proprietary software. Such durable margin levels support reinvestment, shareholder returns and insulating profitability against variability in top-line growth over the medium term.
Much Improved LeverageMaterial deleveraging to a D/E of ~0.06 and healthy ROE indicate a stronger capital structure and greater financial flexibility. This durable improvement reduces refinancing and solvency risk, enabling strategic investment and M&A optionality while lowering fixed interest burdens over coming quarters.
Bears Say
Margin Compression TrendCompression of gross and net margins versus prior years suggests rising unit costs, pricing pressure, or lower operational leverage as the company scales. If sustained, this erodes free cash generation and ROIC, limiting the firm's ability to fund growth and defend competitive positioning over the medium term.
Volatile Cash GenerationDeclining operating cash flow despite revenue growth and consecutive FCF drops indicate inconsistent cash conversion. Persistent volatility constrains internal funding for capex, R&D, or dividends and raises reliance on external financing, increasing execution and liquidity risk across business cycles.
Historic Balance-sheet WeaknessPrior episodes of negative equity and elevated leverage highlight earlier structural fragility. Although the balance sheet improved recently, the short duration of recovery raises questions about resilience to stress and the consistency of capital management, requiring monitoring of sustained deleveraging.
153A FAQ
What was Caulis, Inc.’s price range in the past 12 months?
Caulis, Inc. lowest stock price was ¥688.00 and its highest was ¥2888.00 in the past 12 months.
What is Caulis, Inc.’s market cap?
Caulis, Inc.’s market cap is ¥7.29B.
When is Caulis, Inc.’s upcoming earnings report date?
Caulis, Inc.’s upcoming earnings report date is May 14, 2026 which is in 47 days.
How were Caulis, Inc.’s earnings last quarter?
Caulis, Inc. released its earnings results on Feb 13, 2026. The company reported ¥8.88 earnings per share for the quarter, beating the consensus estimate of N/A by ¥8.88.
Is Caulis, Inc. overvalued?
According to Wall Street analysts Caulis, Inc.’s price is currently Overvalued.
Does Caulis, Inc. pay dividends?
Caulis, Inc. pays a Notavailable dividend of ¥4.8 which represents an annual dividend yield of N/A. See more information on Caulis, Inc. dividends here
What is Caulis, Inc.’s EPS estimate?
Caulis, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Caulis, Inc. have?
Caulis, Inc. has 6,530,800 shares outstanding.
What happened to Caulis, Inc.’s price movement after its last earnings report?
Caulis, Inc. reported an EPS of ¥8.88 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.985%.
Which hedge fund is a major shareholder of Caulis, Inc.?
Currently, no hedge funds are holding shares in JP:153A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Caulis, Inc.
Caulis, Inc. (153A) is a biotechnology company specializing in the development of innovative agricultural solutions and biopesticides aimed at enhancing crop productivity and sustainability. The company focuses on harnessing natural plant-based compounds and advanced biotechnological methods to create products that protect crops from pests and diseases while minimizing environmental impact. Caulis, Inc. operates primarily within the agricultural sector, catering to farmers and agricultural businesses seeking eco-friendly alternatives to traditional chemical pesticides.